Ambroxol chaperone therapy for neuronopathic Gaucher disease: A pilot study.
about
Pharmaceutical Chaperones and Proteostasis Regulators in the Therapy of Lysosomal Storage Disorders: Current Perspective and Future Promises.Gaucher disease: Progress and ongoing challenges.Small molecules as therapeutic agents for inborn errors of metabolism.The Complicated Relationship between Gaucher Disease and Parkinsonism: Insights from a Rare Disease.Cognitive and motor functioning in elderly glucocerebrosidase mutation carriers.Ambroxol for the treatment of fibromyalgia: science or fiction?A Prospective Treatment Option for Lysosomal Storage Diseases: CRISPR/Cas9 Gene Editing Technology for Mutation Correction in Induced Pluripotent Stem Cells.Characteristics of 26 patients with type 3 Gaucher disease: A descriptive analysis from the Gaucher Outcome Survey.Demographics and patient characteristics of 1209 patients with Gaucher disease: Descriptive analysis from the Gaucher Outcome Survey (GOS).Effects of ambroxol on the autophagy-lysosome pathway and mitochondria in primary cortical neurons.Ambroxol for fibromyalgia: one group pretest-posttest open-label pilot study.Dysregulation of the autophagic-lysosomal pathway in Gaucher and Parkinson's disease.Modeling Parkinson's Disease in Drosophila: What Have We Learned for Dominant Traits?Tuning protein folding in lysosomal storage diseases: the chemistry behind pharmacological chaperones.Pharmacotherapy of Gaucher Disease: Current and Future Options.
P2860
Q38652950-61F7A844-08D7-46B1-8B39-34AC020690E0Q39028972-23E77C4E-A040-4AF1-8E64-C470F660AC45Q39038060-9EEE0A94-C225-4C19-AC7C-613112AF6D05Q39148146-FD9892F8-F2EE-4478-997D-2D822D3BD6AEQ40114382-5B61286D-D70E-48B9-85DC-8F5DAF676449Q41483222-A02905EE-972E-4BE4-8A59-37A400F16F84Q42226747-D29A62BA-937D-4C98-9171-2CFCD079F224Q47377712-9D394D8D-F795-4069-B0D7-3E8A620DEB1EQ48091055-BBC6E4A4-1470-4ADA-97BB-50FCAC262587Q48181256-3FF3153A-B48B-431B-BC43-A61EDF334972Q48201932-1906B49C-B428-49A4-9055-7D6A39FBC152Q52689754-6B3AB0F2-3E62-410B-856D-0861D054CBFCQ54114687-E42CE53B-81B5-416B-8A33-C49B67609EA3Q54945677-CEB9D21E-D962-4906-9593-AEBF41646C88Q55062298-ABCC31AF-6766-4D5E-BEFF-580B2898B592
P2860
Ambroxol chaperone therapy for neuronopathic Gaucher disease: A pilot study.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Ambroxol chaperone therapy for neuronopathic Gaucher disease: A pilot study.
@ast
Ambroxol chaperone therapy for neuronopathic Gaucher disease: A pilot study.
@en
type
label
Ambroxol chaperone therapy for neuronopathic Gaucher disease: A pilot study.
@ast
Ambroxol chaperone therapy for neuronopathic Gaucher disease: A pilot study.
@en
prefLabel
Ambroxol chaperone therapy for neuronopathic Gaucher disease: A pilot study.
@ast
Ambroxol chaperone therapy for neuronopathic Gaucher disease: A pilot study.
@en
P2093
P2860
P356
P1476
Ambroxol chaperone therapy for neuronopathic Gaucher disease: A pilot study
@en
P2093
Akiko Ishihara
Akiko Tamasaki
Anri Hayashi
Atsue Matsuda
Chisako Fukuda
Eiji Nanba
Hideo Shigematsu
Hiroshi Nishida
Katsumi Higaki
Kentarou Shirai
P2860
P304
P356
10.1002/ACN3.292
P50
P577
2016-02-02T00:00:00Z